FTRE
Price
$5.70
Change
+$0.42 (+7.95%)
Updated
Jun 9, 02:29 PM (EDT)
Capitalization
477.84M
70 days until earnings call
OCUL
Price
$8.87
Change
-$0.16 (-1.77%)
Updated
Jun 9, 02:55 PM (EDT)
Capitalization
1.44B
63 days until earnings call
Interact to see
Advertisement

FTRE vs OCUL

Header iconFTRE vs OCUL Comparison
Open Charts FTRE vs OCULBanner chart's image
Fortrea Holdings
Price$5.70
Change+$0.42 (+7.95%)
Volume$1.95K
Capitalization477.84M
Ocular Therapeutix
Price$8.87
Change-$0.16 (-1.77%)
Volume$500
Capitalization1.44B
FTRE vs OCUL Comparison Chart
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. OCUL commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Buy and OCUL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (FTRE: $4.18 vs. OCUL: $7.89)
Brand notoriety: FTRE and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 76% vs. OCUL: 184%
Market capitalization -- FTRE: $477.84M vs. OCUL: $1.44B
FTRE [@Biotechnology] is valued at $477.84M. OCUL’s [@Biotechnology] market capitalization is $1.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, FTRE is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 4 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • FTRE’s TA Score: 4 bullish, 4 bearish.
  • OCUL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both FTRE and OCUL are a good buy in the short-term.

Price Growth

FTRE (@Biotechnology) experienced а -0.48% price change this week, while OCUL (@Biotechnology) price change was +8.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.70%. For the same industry, the average monthly price growth was +19.60%, and the average quarterly price growth was +6.76%.

Reported Earning Dates

FTRE is expected to report earnings on Aug 18, 2025.

OCUL is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+10.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.44B) has a higher market cap than FTRE($478M). OCUL YTD gains are higher at: -7.611 vs. FTRE (-77.587). FTRE has higher annual earnings (EBITDA): -64.3M vs. OCUL (-176.14M). OCUL has more cash in the bank: 392M vs. FTRE (118M). OCUL has less debt than FTRE: OCUL (75.8M) vs FTRE (1.2B). FTRE has higher revenues than OCUL: FTRE (2.7B) vs OCUL (63.7M).
FTREOCULFTRE / OCUL
Capitalization478M1.44B33%
EBITDA-64.3M-176.14M37%
Gain YTD-77.587-7.6111,019%
P/E RatioN/AN/A-
Revenue2.7B63.7M4,232%
Total Cash118M392M30%
Total Debt1.2B75.8M1,580%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTREOCUL
RSI
ODDS (%)
Bullish Trend 13 days ago
67%
Bearish Trend 13 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 13 days ago
80%
Bearish Trend 13 days ago
85%
Momentum
ODDS (%)
Bearish Trend 13 days ago
84%
Bullish Trend 13 days ago
80%
MACD
ODDS (%)
Bearish Trend 13 days ago
79%
Bullish Trend 13 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
82%
Bullish Trend 13 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
81%
Bullish Trend 13 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
69%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 25 days ago
84%
Bearish Trend 19 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 13 days ago
72%
Bearish Trend 13 days ago
80%
Aroon
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with DNLI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+0.72%
DNLI - FTRE
44%
Loosely correlated
-1.29%
XERS - FTRE
41%
Loosely correlated
-1.04%
TECH - FTRE
41%
Loosely correlated
-1.56%
BHVN - FTRE
40%
Loosely correlated
-1.83%
OCUL - FTRE
39%
Loosely correlated
+13.69%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+13.69%
EYPT - OCUL
62%
Loosely correlated
+18.12%
IMVT - OCUL
52%
Loosely correlated
-1.33%
DNLI - OCUL
51%
Loosely correlated
-1.29%
XENE - OCUL
49%
Loosely correlated
-3.29%
BEAM - OCUL
49%
Loosely correlated
-0.88%
More